LCAP lung cancer-associated protein

a high MW glycoprotein, defined by monoclonal antibodies DF-L1 & DF-L2 that circulates at elevated levels in patients with lung cancer; do not confuse with leukocytapheresis (LCAP)

Also Known As:

lung cancer-associated protein, LCAP; LCAP tumor marker; lung cancer marker LCAP

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - LCAP lung cancer-associated protein: 2
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - LCAP lung cancer-associated protein: 2

Related Diseases

1.	Lung Neoplasms (Lung Cancer) 08/01/1991 - "This lung cancer-associated protein (LCAP) has been shown to circulate in the plasma of patients with lung cancer. "
2.	Adenocarcinoma 04/01/1997 - "Lung Cancer Associated Protein (LCAP) is a high molecular weight glycoprotein defined by the monoclonal antibody (MAb) DF-L1 prepared against a primary adenocarcinoma of the lung. "

Related Drugs and Biologics

1.	Glycoproteins (Glycoprotein)
2.	Monoclonal Antibodies